Dr. B
Dr. B is a US telehealth platform offering AI-assisted online medical consultations reviewed by licensed providers, starting at $19 without insurance, and delivering prescriptions to major retail pharmacies for 30+ conditions including primary care, dermatology, sexual health, and longevity programs.
- Company typePrivate
- Founded2021
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Dr. B does
Dr. B, PBC is a US telehealth company founded in 2020–2021 by Cyrus Massoumi and headquartered in New York. It operates a direct-to-consumer platform, accessible via website and mobile app, that delivers AI-assisted online medical consultations reviewed and authorized by licensed physicians and nurse practitioners across all 50 states on a 24/7 basis. Standard consultations are priced at $19 with no insurance required, and prescriptions are routed to the patient's chosen retail pharmacy among Walmart, Walgreens, Target, CVS, and Costco.
The platform's service surface spans four treatment categories: Primary Care (UTIs, allergies, hypertension, flu, and other common conditions), Dermatology (hair loss, eczema, rosacea, and similar), Sexual and Reproductive Health (birth control, ED, herpes), and a Longevity vertical that includes the Shed It medical weight loss program with GLP-1 medications, Optimize It hormone replacement therapy, and HSA/FSA-eligible fitness, nutrition, and rehabilitation programs. Underlying technology combines a text-based AI consultation intake with provider review and a pharmacy routing layer that displays medication price comparisons across local and online pharmacies. A No-Cost Care program funded by a portion of paid consultations has delivered over 25,000 free visits to qualifying patients.
The business model is primarily transactional, with $19 per-consultation unit pricing for acute care, supplemented by higher-priced monthly Longevity subscriptions. Distribution is product-led and self-serve, with no enterprise channel; growth relies on direct website traffic, social media presence, and earned media coverage. The company is structured as a Delaware Public Benefit Corporation, is a Certified B Corporation and LegitScript-approved, and has raised a single disclosed $8 million seed round in August 2022 from Lerer Hippeau, Founders Fund, LeFrak, Life Extension Ventures, and Pareto Holdings.
Dr. B firmographics
Firmographics- Name
- Dr. B
- Legal name
- Dr. B, PBC
- Website
- https://hidrb.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Dr. B is a US telehealth platform offering AI-assisted online medical consultations reviewed by licensed providers, starting at $19 without insurance, and delivering prescriptions to major retail pharmacies for 30+ conditions including primary care, dermatology, sexual health, and longevity programs.
- Ownership category
- akta.pro rank
Dr. B industry classification
Industry- Product category
- Telehealth Services
- NAICS
- Offices of Physicians (except Mental Health Specialists) (621111), Offices of Physicians (62111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Primary Care & General Medicine Virtual Care (HLALAAAA)
- akta.pro secondary industries
- Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD), DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA), Men’s Health Prescribing + Pharmacy Delivery Platforms (HLALAIAJ)
Keywords
Where Dr. B is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
Dr. B business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Consultation Fees: Dr. B charges $19 for most standard online medical consultations. Longevity programs cost more with pricing displayed on treatment pages. Revenue is generated on a per-consultation basis with no subscription requirement.
- No-Cost Care Program: Free consultations provided to patients who qualify due to financial hardship, funded by a portion of paid consultations. Over 25,000 No-Cost Care consultations have been given to date.
- Prescription Medications: Patients pay for prescribed medications at their chosen pharmacy. Dr. B displays medication costs at local and online pharmacies so patients can view lowest-cost options and offers drug discount cards.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard Consultation |
| Freemium | Pay-as-you-go | No-Cost Care |
| Subscription | Monthly | Longevity Programs |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Dr. B product offering
Product offeringCore offering
Dr. B is a direct-to-consumer telehealth platform that provides affordable online medical consultations starting at $19, where patients complete AI-powered intake that is reviewed by state-licensed doctors and nurse practitioners. Prescriptions for 30+ conditions across Primary Care, Dermatology, Sexual + Reproductive Health, and Longevity (including GLP-1-based weight loss and hormone therapy) are routed to the patient's chosen pharmacy, with a No-Cost Care program subsidizing free consultations for financially qualifying patients.
Product overview
Dr. B is a unified telehealth platform offering AI-assisted online medical consultations with licensed providers across the United States. The platform provides prescription medications for over 30+ conditions organized into four main treatment areas: Primary Care (common conditions like UTIs, allergies, flu), Dermatology (skin and hair conditions), Sexual + Reproductive Health, and Longevity programs. The Longevity suite includes Shed It (medical weight loss with GLP-1 medications), Optimize It (hormone therapy for women), and HSA/FSA-eligible fitness, nutrition, and rehabilitation programs. The platform also offers No-Cost Care for financially qualifying patients. Originally launched in August 2022 focusing on COVID-19 antivirals (Paxlovid and molnupiravir), Dr. B has expanded to become a comprehensive affordable telehealth service starting at $19 per consultation with no insurance required.
Differentiator
Problem solved
Functional benefit
Products and services
- Dr. B Telehealth Platform A telehealth platform offering AI-assisted online medical consultations reviewed by licensed doctors and nurse practitioners across the United States, providing affordable prescription medications for 30+ conditions without requiring insurance or in-person visits.
- Primary Care
Companies that use Dr. B
Customer profileSegments3 records
Ideal customer profiles3 records
Dr. B technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
AI capability2 records
Feature2 records
Dr. B partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Paxlovid (Pfizer)coreDr. B initially launched with focus on COVID-19 antiviral treatments, offering Paxlovid and molnupiravir. These medications are provided through prescriptions sent to patient-chosen pharmacies.
- Molnupiravir (Merck)coreDr. B initially launched with focus on COVID-19 antiviral treatments, offering molnupiravir alongside Paxlovid. These medications are provided through prescriptions sent to patient-chosen pharmacies.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Dr. B competitors and assessment
Company assessmentEmerging players
- Curology: DTC telehealth brand specializing in prescription dermatology (acne, anti-aging, hyperpigmentation) with a custom-formulation model — directly comparable to Dr. B's dermatology offering but with deeper specialty focus.
Direct peers
- Nurx: Direct-to-consumer telehealth company focused on sexual and reproductive health (birth control, STI testing, HPV) with prescription delivery — overlaps significantly with Dr. B's Sexual + Reproductive Health vertical.
- Lemonaid Health: Telehealth platform offering low-cost online consultations and prescriptions for primary care, mental health, and reproductive health — closely mirrors Dr. B's $19-style pricing and condition-specific Rx model.
- GoodRx: Public consumer healthcare platform combining prescription discount cards with telehealth consultations (GoodRx Care) — directly comparable cash-pay model and emphasis on affordable medication access for uninsured patients.
- Ro: Direct-to-consumer telehealth company offering cash-pay treatments across weight loss (GLP-1s via Ro Body), ED, hair, fertility, and primary care — closest product-by-product overlap with Dr. B's Primary Care, Sexual + Reproductive Health, and Shed It offerings.
- K Health: AI-driven primary care telehealth platform offering 24/7 consultations and prescriptions; competes head-on with Dr. B's AI-consult-with-provider-review architecture and primary-care-first positioning.
- Hims & Hers Health: Public direct-to-consumer telehealth platform offering cash-pay prescription treatments for hair loss, ED, weight loss (GLP-1s), primary care, and dermatology — the most direct large-scale comparable to Dr. B's catalog and cash-pay model.
Broad incumbents
- MDLive (Evernorth/Cigna): Established telehealth platform owned by Cigna's Evernorth, providing primary care, behavioral health, and dermatology — a broad incumbent competing for the same patient demand, primarily via insurance rather than cash pay.
- Teladoc Health: Large incumbent virtual care provider offering primary care, mental health, and specialty telehealth to insurers and employers — operates at greater scale and through payer channels rather than Dr. B's direct cash-pay model.
Others
- Walmart Health (telehealth and pharmacy services): Walmart operates one of Dr. B's pharmacy distribution partners and has piloted its own low-cost telehealth and primary care services — represents both a fulfillment partner and a potential vertical integrator threat.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Dr. B social profiles
Digital presenceDr. B compliance and trust
Trust signalCompliance2 records
Dr. B financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dr. B leadership team
Management profileNumber of profiles
Profiles5 records
Dr. B funding detail
Funding detailFunding overview
Funding rounds1 record
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dr. B M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dr. B
What does Dr. B do?
Dr. B is a direct-to-consumer telehealth platform that provides affordable online medical consultations starting at $19, where patients complete AI-powered intake that is reviewed by state-licensed doctors and nurse practitioners. Prescriptions for 30+ conditions across Primary Care, Dermatology, Sexual + Reproductive Health, and Longevity (including GLP-1-based weight loss and hormone therapy) are routed to the patient's chosen pharmacy, with a No-Cost Care program subsidizing free consultations for financially qualifying patients.
Is Dr. B a public or private company?
Dr. B is a private company. It is classified as venture growth investor backed and is currently operating.
When was Dr. B founded?
Dr. B was founded in 2021. It employs 11 to 50 people.
Where is Dr. B based?
Dr. B is headquartered in New York, United States, in the North America region.
How does Dr. B make money?
Three revenue lines are on record. Consultation Fees are the primary driver. The others are no-Cost Care Program and prescription Medications.
Who are Dr. B's main competitors?
Curology is listed as an emerging player. Direct peers are Nurx, Lemonaid Health, GoodRx, Ro, K Health and Hims & Hers Health. Broad incumbents are MDLive (Evernorth/Cigna) and Teladoc Health. Walmart Health (telehealth and pharmacy services) is listed as an others.
Does Dr. B have an API?
No public API is recorded for Dr. B.
What industry is Dr. B in?
Dr. B's product category is Telehealth Services. Its primary akta.pro industry code is HLALAAAA, Primary Care & General Medicine Virtual Care, with a secondary code of HLALAAAD, Prescription-Based Digital Clinics (Condition-Specific Rx Programs). Its NAICS code is 621111 and its SIC code is 8011.